Alerts
COVID-19 update
See our updated visitor policy, which allows 1 visitor per patient during exams only and includes masking for all. No visitors are allowed in treatment (applies at all locations). Only exceptions are patients with physical or mental disability.
Skip Navigation

NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Prevention

Phase:
II

ClinicalTrials.gov Identifier:
NCT02679144

Study #:
CMH - NMTRC014

Start Date:
Mar 02, 2016

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02679144

View Complete Trial Details & Eligibility at ClinicalTrials.gov